Results 1 to 10 of about 77,268 (108)

Modified rush venom immunotherapy in dogs with Hymenoptera hypersensitivity

open access: yesVeterinary Dermatology, Volume 34, Issue 6, Page 532-542, December 2023., 2023
Background – Hymenoptera envenomation occurs frequently in people and dogs and can trigger anaphylaxis. Venom immunotherapy (VIT) is the only preventative treatment for Hymenoptera hypersensitivity and is indicated for people with severe adverse reactions to insect stings. Rush VIT is an accelerated VIT induction schedule performed in people.
Alexandra Moore   +4 more
wiley   +1 more source

The safety of rush immunotherapy in the management of canine atopic dermatitis—230 cases

open access: yesVeterinary Dermatology, Volume 34, Issue 5, Page 385-392, October 2023., 2023
Background – The duration of the induction phase of allergen‐specific immunotherapy conventionally is a period of several weeks, during which the volume of an allergen solution, administered by injection, is gradually increased until the maintenance dose is reached.
Tamara Weitzer, Ralf Mueller
wiley   +1 more source

Janus kinase inhibitor ruxolitinib in combination with nilotinib and prednisone in patients with myelofibrosis (RuNiC study): A phase Ib, multicenter study

open access: yeseJHaem, Volume 4, Issue 2, Page 401-409, May 2023., 2023
Abstract This phase Ib, non‐randomized, open‐label study evaluates the safety and tolerability of ruxolitinib in combination with nilotinib and prednisone in patients with naïve or ruxolitinib‐resistant myelofibrosis (MF). A total of 15 patients with primary or secondary MF received the study treatment; 13 patients had received prior ruxolitinib ...
Rosa Ayala   +12 more
wiley   +1 more source

COVID‐19 disease in professional football players: symptoms and impact on pulmonary function and metabolic power during matches

open access: yesPhysiological Reports, Volume 10, Issue 11, June 2022., 2022
“General fatigue” and “muscle fatigue” symptoms were the most common long‐term COVID‐19 symptoms reported. Players’ capability to exercise at high intensity was compromised following COVID‐19. Players’ pulmonary function was not affected by COVID‐19, even though some impairments were observed at the individual level.
Chiara Gattoni   +6 more
wiley   +1 more source

Experiences of food and mealtime from the perspective of patients with chronic life‐limiting disease: A mixed‐method systematic review

open access: yesJournal of Advanced Nursing, Volume 77, Issue 11, Page 4400-4413, November 2021., 2021
Abstract Aim To describe and synthesise experiences of food and mealtimes from the perspective of patients with chronic life‐limiting disease. Design A mixed‐method systematic review. Data Sources The databases Academic Search Complete, CINAHL, Nursing and Allied Health Database, PsycINFO, PubMed, Soc Index and Web of Science Core Collection were ...
Viktoria Wallin   +3 more
wiley   +1 more source

The usefulness of a hydrolysed fish and rice starch elimination diet for the diagnosis of adverse food reactions in cats: an open clinical trial

open access: yesVeterinary Dermatology, Volume 32, Issue 4, Page 326-e90, August 2021., 2021
Background Diagnosis of adverse food reaction (AFR) is based on an eight week elimination diet (ED) and is confirmed by relapse upon re‐challenge with the previously fed diet. Hydrolysed EDs are commonly used for this purpose. Objective To evaluate the commercially available hydrolysed fish protein and rice starch ED Farmina UltraHypo (FUH) for the ...
Chiara Noli, Giorgia Beltrando
wiley   +1 more source

Epitope mapping of anti‐amelogenin IgG in untreated celiac children

open access: yesEuropean Journal of Oral Sciences, Volume 129, Issue 2, April 2021., 2021
Abstract Children with untreated celiac disease (CeD) may develop enamel defects, and children with severe CeD have significantly increased levels of IgG to amelogenin, which may interfere with normal amelogenesis depending on which epitope(s) they bind.
Sanja Petronijevic   +2 more
wiley   +1 more source

Efficacy and safety of 0.0584% hydrocortisone aceponate topical spray and systemic oclacitinib combination therapy in dogs with atopic dermatitis: a randomized, double‐blinded, placebo‐controlled trial

open access: yesVeterinary Dermatology, Volume 32, Issue 2, Page 119-e25, April 2021., 2021
Background – Oclacitinib is an effective systemic therapy for dogs with atopic dermatitis (AD). Few studies have evaluated concurrent topical treatment with oclacitinib in dogs. Objectives – To evaluate the efficacy and safety of combination therapy of oclacitinib and 0.0584% hydrocortisone aceponate (HCA) spray in dogs with AD.
Junko Takahashi   +9 more
wiley   +1 more source

Patrón de riesgo de la incidencia de diarrea y mortalidad en terneros de lechería en Córdoba, Argentina [PDF]

open access: yes, 2016
El objetivo de este estudio fue determinar la incidencia de diarrea y mortalidad en terneros de 2 a 65 días de edad y los factores de riesgo asociados.
Larriestra, Alejandro José   +2 more
core   +2 more sources

Microvillous inclusion disease as a cause of severe congenital diarrhea. Case report [PDF]

open access: yes, 2017
Indexación: Scopus; Scielo.Introducción: Las diarreas congénitas son patologías graves de baja frecuencia y alta mortalidad. Se manifiestan durante los primeros días o meses de vida con severa diarrea, generando insuficiencia intestinal y dependencia de ...
Espinosa, R.   +5 more
core   +1 more source

Home - About - Disclaimer - Privacy